Core Viewpoint - A class action lawsuit has been filed against Semler Scientific, Inc. for allegedly making false and misleading statements regarding a material investigation by the U.S. Department of Justice related to the False Claims Act, which has resulted in investor losses [3][7]. Allegation Details - The lawsuit claims that Semler Scientific failed to disclose a significant investigation by the DOJ into potential violations of the False Claims Act while discussing such violations in hypothetical terms [3]. - As a result of these omissions, the public statements made by the defendants were materially false and misleading throughout the relevant period [3]. Next Steps for Investors - Investors who purchased Semler shares between March 10, 2021, and April 15, 2025, and suffered losses are encouraged to contact the law firm Bragar Eagel & Squire for more information and to discuss their legal rights [4][7]. - The deadline for investors to apply to be appointed as lead plaintiff in the lawsuit is October 28th [7]. About the Law Firm - Bragar Eagel & Squire, P.C. is a nationally recognized law firm that represents individual and institutional investors in complex litigation across various courts in the United States [5].

Core Points - A class action lawsuit has been filed against Semler Scientific, Inc. for allegedly making materially false and misleading statements regarding a Department of Justice investigation into violations of the False Claims Act [3][7] - The lawsuit claims that investors who purchased Semler securities between March 10, 2021, and April 15, 2025, suffered damages when the true details of the investigation were revealed [3][7] - Investors have until October 28th to apply to the Court to be appointed as lead plaintiff in the lawsuit [7] Allegation Details - The complaint alleges that Semler Scientific failed to disclose a material investigation by the DOJ while discussing potential violations of the False Claims Act in hypothetical terms [3] - Defendants' public statements were claimed to be materially false and misleading at all relevant times due to the lack of disclosure regarding the investigation [3] Next Steps - Investors who suffered losses and are interested in learning more about the claims or have questions are encouraged to contact the law firm Bragar Eagel & Squire, P.C. [4] - There is no cost or obligation for investors to reach out for more information [4] About the Law Firm - Bragar Eagel & Squire, P.C. is a nationally recognized law firm that represents individual and institutional investors in complex litigation across state and federal courts [5] - The firm has offices in New York, California, and South Carolina [5]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Semler Scientific, Inc. securities between March 10, 2021, and April 15, 2025, about the upcoming lead plaintiff deadline for a securities class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Semler Scientific securities during the specified Class Period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by October 28, 2025 [3]. - The lawsuit alleges that Semler Scientific made materially false and misleading statements and failed to disclose a significant investigation by the U.S. Department of Justice regarding violations of the False Claims Act [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success in recovering hundreds of millions of dollars for investors [4]. - The firm achieved the largest securities class action settlement against a Chinese company at the time and has been consistently ranked among the top firms for securities class action settlements since 2013 [4].

Core Viewpoint - Semler Scientific, Inc. is facing a class action lawsuit related to securities purchased between March 10, 2021, and April 15, 2025, with a deadline for lead plaintiff motion set for October 28, 2025 [1] Group 1 - Semler disclosed a risk of a potential complaint from the U.S. Department of Justice regarding a civil False Claims Act lawsuit, which could seek damages [3] - The company received an initial civil investigative demand from the DOJ in July 2017 concerning claims for reimbursement related to its QuantaFlo device [3] - Following the announcement of unsuccessful settlement discussions with the DOJ in February 2025, Semler's stock price dropped by $4.03 per share, or 9.4%, closing at $38.89 on March 3, 2025 [3] Group 2 - The Portnoy Law Firm is representing investors in claims related to corporate wrongdoing and has a history of recovering over $5.5 billion for investors [4]

Core Viewpoint - A class action securities lawsuit has been filed against Semler Scientific, Inc. for alleged securities fraud affecting investors between March 10, 2021, and April 15, 2025 [2][3]. Group 1: Lawsuit Details - The lawsuit claims that Semler Scientific failed to disclose a significant investigation by the U.S. Department of Justice regarding violations of the False Claims Act, while discussing potential violations in hypothetical terms [3]. - The complaint alleges that the public statements made by the defendants were materially false and misleading throughout the relevant period [3]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until October 28, 2025, to request to be appointed as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [4]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, and there is no obligation to participate [4]. Group 3: Legal Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and has been recognized as one of the top securities litigation firms in the U.S. for seven consecutive years [5].

Core Viewpoint - A class action securities lawsuit has been filed against Semler Scientific, Inc. for alleged securities fraud affecting investors between March 10, 2021, and April 15, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Semler Scientific failed to disclose a significant investigation by the U.S. Department of Justice regarding violations of the False Claims Act, while discussing potential violations in hypothetical terms [2]. - As a result of these omissions, the public statements made by the defendants were materially false and misleading throughout the relevant period [2]. Group 2: Next Steps for Investors - Investors who experienced losses in Semler Scientific during the specified timeframe have until October 28, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be eligible for compensation without incurring any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and has been recognized as one of the top securities litigation firms in the U.S. for seven consecutive years [4].

Company Overview - Seun Sodipo has been appointed as the new Chief Financial Officer (CFO) of Plaid, a fintech startup that connects financial institutions, succeeding Eric Hart [1][3] - Sodipo has a strong background in guiding high-growth businesses, having previously served as CFO at Glossier and held key roles at Stripe, Centerview Partners, Helios Investment Partners, and Insignia Capital Group [3] Recent Developments - In April, Plaid completed a $575 million funding round led by Franklin Templeton, valuing the company at approximately $6.1 billion, despite a drop from its peak valuation of $13.4 billion in 2021 [4][5] - The funding round included a tender offer, allowing investors to purchase existing shares and providing liquidity to Plaid employees, addressing tax obligations tied to expiring stock units [4] Strategic Focus - Plaid aims to expand beyond core data infrastructure into a broader suite of intelligence services, including products in identity, payments, credit, and fraud [5] - Sodipo's priorities as CFO include driving sustainable, long-term growth, investing in areas of strong customer demand, and enhancing data and analytics capabilities [7] - The company is positioned to support the next era of digital finance, with over half of Americans with bank accounts having used Plaid to connect to apps or services [7]

Core Points - Rosen Law Firm is reminding purchasers of Semler Scientific, Inc. securities about a lead plaintiff deadline for a class action lawsuit [1] - Investors who purchased Semler Scientific securities during the specified class period may be entitled to compensation without upfront costs [2] - A class action lawsuit has already been filed, and interested parties must act by the deadline to serve as lead plaintiff [3] Legal Context - The lawsuit alleges that Semler Scientific made materially false and misleading statements and failed to disclose a significant investigation by the U.S. Department of Justice regarding violations of the False Claims Act [5] - The lawsuit claims that these misstatements led to investor damages when the true information became public [5] Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4] - The firm has achieved significant settlements for investors, including over $438 million in 2019 alone, and has been recognized for its performance in securities class action settlements [4]

Core Points - A class action lawsuit has been filed against Semler Scientific, Inc. for allegedly making materially false and misleading statements regarding a Department of Justice investigation into violations of the False Claims Act during the Class Period from March 10, 2021, to April 15, 2025 [3][7] - Investors who purchased Semler securities during the Class Period and suffered losses are encouraged to contact the law firm Bragar Eagel & Squire for legal options [1][4] Allegation Details - The lawsuit claims that Semler Scientific failed to disclose a material investigation by the DOJ into potential violations of the False Claims Act, while discussing such violations in hypothetical terms [3] - As a result of these alleged omissions, the public statements made by the defendants were deemed materially false and misleading [3] Next Steps - Investors who acquired Semler shares and experienced losses are invited to reach out to the law firm for more information or to discuss their rights [4][7] - The deadline for investors to apply to be appointed as lead plaintiff in the lawsuit is October 28th [7] About the Law Firm - Bragar Eagel & Squire, P.C. is a nationally recognized law firm that represents individual and institutional investors in complex litigation across various courts in the United States [5]

Core Viewpoint - A class action securities lawsuit has been filed against Semler Scientific, Inc. for alleged securities fraud affecting investors between March 10, 2021, and April 15, 2025 [1][2] Group 1: Lawsuit Details - The lawsuit claims that Semler Scientific failed to disclose a significant investigation by the U.S. Department of Justice regarding violations of the False Claims Act, while discussing potential violations in hypothetical terms [2] - As a result of these omissions, the public statements made by the defendants were materially false and misleading throughout the relevant period [2] Group 2: Next Steps for Investors - Investors who experienced losses in Semler Scientific during the specified timeframe have until October 28, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving as lead plaintiff [3] - Class members may be eligible for compensation without incurring any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and has been recognized as one of the top securities litigation firms in the U.S. for seven consecutive years [4]